TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science ...

TriLink BioTechnologies, a Maravai LifeSciences company (MRVI), has partnered with, Avantor (AVTR) to expand availability of its innovative ...

TriLink BioTechnologies, a Maravai LifeSciences company and provider of life science reagents and services, has partnered ...

Despite hosting more oncology start-ups, Europe is lagging in the development of cancer technologies, losing the competitive ...

A recent study described develops methods for synthesizing and quantifying metal-induced glycation products, particularly in ...

Genetic medicines could treat certain diseases, however, the current delivery systems available—viral vectors and lipid nanoparticles (LNPs)—pose unique challenges for gene therapy applications. For ...

AliveDx’s CE mark for the systematic autoimmune rheumatic disease (SARD) assay marks its fifth approval in the past 18 months.

Advance quantum information systems through innovative material design. Develop ultrasensitive biosensors for non-invasive ...

There are notable differences between men and women in their susceptibility to many human diseases, including cardiovascular ...

KBR announced today its participation in upcoming February 2025 investor conferences. TD Cowen 46th Annual Aerospace and ...

MIAMI, Feb. 3, 2025 /PRNewswire-PRWeb/ -- kluster.ai, the decentralized AI platform, became the first to market to host DeepSeek-R1. The model matches OpenAI's performance in logic, mathematics, and ...

In µSR spectroscopy, a unique particle called muonium (Mu) is formed when a muon captures an electron. This muonium reacts ...